Skip to main content

13.07.2019 | Global Breast Cancer (AB Chagpar, Section Editor) | Ausgabe 3/2019

Current Breast Cancer Reports 3/2019

Breast Cancer Treatment in Resource Constrained Countries: a Zimbabwean Perspective

Current Breast Cancer Reports > Ausgabe 3/2019
Webster Kadzatsa, Sandra Ndarukwa-Jambwa
Wichtige Hinweise
This article is part of the Topical Collection on Global Breast Cancer

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Purpose of Review

Breast cancer is becoming a significant burden to the healthcare system in Zimbabwe. The financial toxicity of breast cancer treatment is a significant problem for patients even in the developed world. This review looks at the management of breast cancer patients in Zimbabwe relating it to the other developed nations.

Recent Findings

Despite the tremendous progress made by science in the care of women with breast cancer over the past few decades, most of the women in Zimbabwe are yet to benefit from this progress. There is poor access to modern screening methods, quality chemotherapy drugs and reliable radiotherapy services and lack of evidence-based medicine derived from our own settings. Out-of-pocket payments for healthcare are still the major health-funding model, and it denies most women access to quality and appropriate healthcare services.


An increase in the number of medical specialists treating breast cancer over the past 10 years has resulted in a slight improvement in diagnostic and treatment capability of the country; however, resources for breast cancer management in Zimbabwe remain far from being adequate. Universal health coverage (UHC) if achieved through the drive to attain the 17 Sustainable Development Goals (SDGs) will improve care for breast cancer patients.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Weitere Produktempfehlungen anzeigen
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2019

Current Breast Cancer Reports 3/2019 Zur Ausgabe

Global Breast Cancer (AB Chagpar, Section Editor)

Bridging the Gap in Training and Clinical Practice in Sub-Saharan Africa

Risk and Prevention (ME Wood, Section Editor)

Breast Atypia as a Biomarker of Risk

Local-Regional Evaluation and Therapy (DM Euhus, Section Editor)

Ductal Carcinoma In Situ Management: All or Nothing, or Something in between?

Local-Regional Evaluation and Therapy (DM Euhus, Section Editor)

Pathology Meets Biology: the New Era of Breast Cancer Staging

  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.